Search - tctmd.com

Displaying 501 - 520 of 984

Sort: Relevancy | Date

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

News Daily News

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

June 04, 2020

Cardiology Societies Unite to Condemn Racism and Health Inequality

News Daily News

Cardiology Societies Unite to Condemn Racism and Health Inequality

June 01, 2020

June 2020 News Roundup

News Daily News

June 2020 News Roundup

June 01, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

News Daily News

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

June 01, 2020

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

News Daily News

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

May 29, 2020

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

News Daily News

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

May 28, 2020

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

Takotsubo Rising During COVID-19? Stress, Viral Triggers Need Attention

News Daily News

Takotsubo Rising During COVID-19? Stress, Viral Triggers Need Attention

Yael L. Maxwell

May 08, 2020

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

May 06, 2020

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

Many STEMI Patients With COVID-19 Have No Obstructed Arteries

News Daily News

Many STEMI Patients With COVID-19 Have No Obstructed Arteries

May 05, 2020

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

Takotsubo Snapshot Reveals Some Surprises: InterTAK Registry

News Daily News

Takotsubo Snapshot Reveals Some Surprises: InterTAK Registry

Yael L. Maxwell

April 27, 2020

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

April 02, 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

March 31, 2020

Ischemia Burden Not Linked to Angina in Nonobstructive CAD: CIAO

News Conference News ACC 2020

Ischemia Burden Not Linked to Angina in Nonobstructive CAD: CIAO

Michael O'Riordan

March 31, 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

March 30, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.